John Canepa

About John Canepa

John Canepa is an experienced business and financial executive and entrepreneur. Most recently, Mr. Canepa was Chief Financial Officer of Agilis Biotherapeutics, Inc., a pediatric gene therapy company, which was acquired by PTC Therapeutics in August 2018. He previously served as Chief Operating Officer and Chief Financial Officer of Asterand Biosciences, a global leader in the procurement and sale of human tissue and tissue-based research solutions for drug and diagnostic development, where he led the acquisition, rebranding and eventual successful sale of the company in August 2017.

Before working in life sciences, Mr. Canepa was part of a team of entrepreneurs at a venture-backed company in the wireless telecom infrastructure industry that was successfully sold in 2003. He previously spent 23 years with the international public accounting firm, Arthur Andersen, working primarily with technology-based enterprises. During that time, Mr. Canepa led the Boston office's technology practice and was the worldwide leader of the firm's life science practice.

An active member of the Mount Auburn Hospital community for more than 20 years, Mr. Canepa has served as Co-Chair of the Mount Auburn Hospital Board of Trustees.

Mr. Canepa received his undergraduate degree from Denison University and his Master of Finance from Michigan State University.